We got a number of important drugs from the Celgene acquisition, says Bristol Myers Squibb CEO
Share- Nishadil
- January 09, 2024
- 0 Comments
- 1 minutes read
- 28 Views
Bristol Myers Squibb CEO Christopher Boerner joins 'Mad Money' host Jim Cramer to talk recent acquisitions made by the company, what's ahead for BMY and much more.
Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on
